Literature DB >> 30735627

Macrophage-Mediated Phagocytosis and Dissolution of Amyloid-Like Fibrils in Mice, Monitored by Optical Imaging.

Tina Richey1, James S Foster1, Angela D Williams1, Anna B Williams2, Alexa Stroh3, Sallie Macy1, Craig Wooliver1, R Eric Heidel4, Siva K Varanasi3, Elizabeth N Ergen1, Dianne J Trent5, Stephen A Kania5, Stephen J Kennel1, Emily B Martin1, Jonathan S Wall6.   

Abstract

Light chain-associated amyloidosis is characterized by the extracellular deposition of amyloid fibrils in abdominothoracic organs, skin, soft tissue, and peripheral nerves. Phagocytic cells of the innate immune system appear to be ineffective at clearing the material; however, human light chain amyloid extract, injected subcutaneously into mice, is rapidly cleared in a process that requires neutrophil activity. To better elucidate the phagocytosis of light chain fibrils, a potential method of cell-mediated dissolution, amyloid-like fibrils were labeled with the pH-sensitive dye pHrodo red and a near infrared fluorophore. After injecting this material subcutaneously in mice, optical imaging was used to quantitatively monitor phagocytosis and dissolution of fibrils concurrently. Histologic evaluation of the residual fibril masses revealed the presence of CD68+, F4/80+, ionized calcium binding adaptor molecule 1- macrophages containing Congo red-stained fibrils as well as neutrophil-associated proteins with no evidence of intact neutrophils. These data suggest an early infiltration of neutrophils, followed by extensive phagocytosis of the light chain fibrils by macrophages, leading to dissolution of the mass. Optical imaging of this novel murine model, coupled with histologic evaluation, can be used to study the cellular mechanisms underlying dissolution of synthetic amyloid-like fibrils and human amyloid extracts. In addition, it may serve as a test bed to evaluate investigational opsonizing agents that might serve as therapeutic agents for light chain-associated amyloidosis.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30735627      PMCID: PMC6521888          DOI: 10.1016/j.ajpath.2019.01.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.

Authors:  R Khurana; J R Gillespie; A Talapatra; L J Minert; C Ionescu-Zanetti; I Millett; A L Fink
Journal:  Biochemistry       Date:  2001-03-27       Impact factor: 3.162

2.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 3.  Cardiac amyloidosis.

Authors:  Ana Martinez-Naharro; Philip N Hawkins; Marianna Fontana
Journal:  Clin Med (Lond)       Date:  2018-04-01       Impact factor: 2.659

4.  Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

Authors:  Brian O'Nuallain; Amy Allen; Stephen J Kennel; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Biochemistry       Date:  2007-02-06       Impact factor: 3.162

Review 5.  Daratumumab for the treatment of AL amyloidosis.

Authors:  M Hasib Sidiqi; Morie A Gertz
Journal:  Leuk Lymphoma       Date:  2018-07-22

6.  Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.

Authors:  P N Hawkins; S Richardson; J E MacSweeney; A D King; D M Vigushin; J P Lavender; M B Pepys
Journal:  Q J Med       Date:  1993-06

7.  Phagolysosomal pH of human neutrophils.

Authors:  P Cech; R I Lehrer
Journal:  Blood       Date:  1984-01       Impact factor: 22.113

8.  Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.

Authors:  Emily B Martin; Angela Williams; Eric Heidel; Sallie Macy; Stephen J Kennel; Jonathan S Wall
Journal:  Biochem Biophys Res Commun       Date:  2013-05-23       Impact factor: 3.575

9.  Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain.

Authors:  Benjamin T Fitzgerald; John Bashford; Gregory M Scalia
Journal:  CASE (Phila)       Date:  2017-04-24

10.  Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction.

Authors:  Ronny Milde; Julia Ritter; Glenys A Tennent; Andrzej Loesch; Fernando O Martinez; Siamon Gordon; Mark B Pepys; Admar Verschoor; Laura Helming
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

View more
  1 in total

1.  Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.

Authors:  Taxiarchis V Kourelis; Jose C Villasboas; Erik Jessen; Surendra Dasari; Angela Dispenzieri; Dragan Jevremovic; Shaji Kumar
Journal:  Blood Cancer J       Date:  2019-08-28       Impact factor: 11.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.